Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118520) titled 'Hypertrophic Cardiomyopathy-Atrial Fibrillation Diagnosis & Interventional Management Cohort Registry' on Feb. 6.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
Hypertrophic Cardiomyopathy complicated by Atrial Fibrillation (HCM-AF)
Intervention:
HCM-non AF group:NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: HCM-non AF group:300;HCM-AF group:1200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302179...